nodes	percent_of_prediction	percent_of_DWPC	metapath
Orphenadrine—CYP2B6—Thiotepa—urinary bladder cancer	0.297	0.458	CbGbCtD
Orphenadrine—CYP3A4—Thiotepa—urinary bladder cancer	0.0912	0.141	CbGbCtD
Orphenadrine—CYP2B6—Cisplatin—urinary bladder cancer	0.082	0.126	CbGbCtD
Orphenadrine—CYP2E1—Etoposide—urinary bladder cancer	0.0816	0.126	CbGbCtD
Orphenadrine—CYP2B6—Doxorubicin—urinary bladder cancer	0.0549	0.0847	CbGbCtD
Orphenadrine—CYP3A4—Etoposide—urinary bladder cancer	0.0247	0.0382	CbGbCtD
Orphenadrine—CYP3A4—Doxorubicin—urinary bladder cancer	0.0169	0.026	CbGbCtD
Orphenadrine—GRIN2D—prostate gland—urinary bladder cancer	0.0112	0.109	CbGeAlD
Orphenadrine—SCN9A—prostate gland—urinary bladder cancer	0.00783	0.0764	CbGeAlD
Orphenadrine—CYP2E1—urine—urinary bladder cancer	0.00715	0.0697	CbGeAlD
Orphenadrine—SCN4A—prostate gland—urinary bladder cancer	0.00699	0.0681	CbGeAlD
Orphenadrine—CYP3A4—urine—urinary bladder cancer	0.00575	0.0561	CbGeAlD
Orphenadrine—SCN4A—renal system—urinary bladder cancer	0.00476	0.0464	CbGeAlD
Orphenadrine—CHRM2—prostate gland—urinary bladder cancer	0.00461	0.045	CbGeAlD
Orphenadrine—Drowsiness—Mitomycin—urinary bladder cancer	0.00334	0.031	CcSEcCtD
Orphenadrine—KCNH2—prostate gland—urinary bladder cancer	0.00333	0.0325	CbGeAlD
Orphenadrine—Benzphetamine—POR—urinary bladder cancer	0.00302	0.43	CrCbGaD
Orphenadrine—KCNH2—seminal vesicle—urinary bladder cancer	0.00282	0.0275	CbGeAlD
Orphenadrine—SCN5A—vagina—urinary bladder cancer	0.00268	0.0261	CbGeAlD
Orphenadrine—HRH1—prostate gland—urinary bladder cancer	0.00267	0.026	CbGeAlD
Orphenadrine—CYP2E1—prostate gland—urinary bladder cancer	0.00257	0.025	CbGeAlD
Orphenadrine—Feeling abnormal—Valrubicin—urinary bladder cancer	0.00255	0.0237	CcSEcCtD
Orphenadrine—SCN9A—lymph node—urinary bladder cancer	0.0025	0.0244	CbGeAlD
Orphenadrine—Vision blurred—Mitomycin—urinary bladder cancer	0.00246	0.0228	CcSEcCtD
Orphenadrine—KCNH2—renal system—urinary bladder cancer	0.00227	0.0221	CbGeAlD
Orphenadrine—KCNH2—urethra—urinary bladder cancer	0.00223	0.0218	CbGeAlD
Orphenadrine—Asthenia—Valrubicin—urinary bladder cancer	0.00222	0.0206	CcSEcCtD
Orphenadrine—Pruritus—Valrubicin—urinary bladder cancer	0.00219	0.0203	CcSEcCtD
Orphenadrine—CYP2E1—seminal vesicle—urinary bladder cancer	0.00217	0.0212	CbGeAlD
Orphenadrine—Confusional state—Mitomycin—urinary bladder cancer	0.00215	0.0199	CcSEcCtD
Orphenadrine—Dizziness—Valrubicin—urinary bladder cancer	0.00205	0.019	CcSEcCtD
Orphenadrine—SLC6A2—female reproductive system—urinary bladder cancer	0.00203	0.0198	CbGeAlD
Orphenadrine—Vomiting—Valrubicin—urinary bladder cancer	0.00197	0.0183	CcSEcCtD
Orphenadrine—HRH1—epithelium—urinary bladder cancer	0.00196	0.0191	CbGeAlD
Orphenadrine—Headache—Valrubicin—urinary bladder cancer	0.00194	0.018	CcSEcCtD
Orphenadrine—SCN10A—lymph node—urinary bladder cancer	0.0019	0.0186	CbGeAlD
Orphenadrine—Somnolence—Mitomycin—urinary bladder cancer	0.0019	0.0176	CcSEcCtD
Orphenadrine—HRH1—smooth muscle tissue—urinary bladder cancer	0.00189	0.0184	CbGeAlD
Orphenadrine—CYP2B6—renal system—urinary bladder cancer	0.00186	0.0182	CbGeAlD
Orphenadrine—Nausea—Valrubicin—urinary bladder cancer	0.00184	0.0171	CcSEcCtD
Orphenadrine—KCNH2—female reproductive system—urinary bladder cancer	0.00182	0.0177	CbGeAlD
Orphenadrine—HRH1—urethra—urinary bladder cancer	0.00179	0.0174	CbGeAlD
Orphenadrine—Feeling abnormal—Mitomycin—urinary bladder cancer	0.00176	0.0163	CcSEcCtD
Orphenadrine—CYP2E1—renal system—urinary bladder cancer	0.00175	0.0171	CbGeAlD
Orphenadrine—CYP2E1—urethra—urinary bladder cancer	0.00172	0.0168	CbGeAlD
Orphenadrine—KCNH2—vagina—urinary bladder cancer	0.00165	0.016	CbGeAlD
Orphenadrine—Toremifene—ESR1—urinary bladder cancer	0.00159	0.226	CrCbGaD
Orphenadrine—Asthenia—Mitomycin—urinary bladder cancer	0.00153	0.0142	CcSEcCtD
Orphenadrine—Hallucination—Thiotepa—urinary bladder cancer	0.0015	0.0139	CcSEcCtD
Orphenadrine—CYP2B6—female reproductive system—urinary bladder cancer	0.00149	0.0146	CbGeAlD
Orphenadrine—HRH1—female reproductive system—urinary bladder cancer	0.00146	0.0142	CbGeAlD
Orphenadrine—Dizziness—Mitomycin—urinary bladder cancer	0.00141	0.0131	CcSEcCtD
Orphenadrine—CYP3A4—renal system—urinary bladder cancer	0.00141	0.0137	CbGeAlD
Orphenadrine—CYP2E1—female reproductive system—urinary bladder cancer	0.0014	0.0137	CbGeAlD
Orphenadrine—Vomiting—Mitomycin—urinary bladder cancer	0.00136	0.0126	CcSEcCtD
Orphenadrine—CYP2B6—vagina—urinary bladder cancer	0.00135	0.0132	CbGeAlD
Orphenadrine—Headache—Mitomycin—urinary bladder cancer	0.00134	0.0124	CcSEcCtD
Orphenadrine—HRH1—vagina—urinary bladder cancer	0.00132	0.0129	CbGeAlD
Orphenadrine—Tension—Thiotepa—urinary bladder cancer	0.00129	0.012	CcSEcCtD
Orphenadrine—Nausea—Mitomycin—urinary bladder cancer	0.00127	0.0118	CcSEcCtD
Orphenadrine—Vision blurred—Thiotepa—urinary bladder cancer	0.00124	0.0115	CcSEcCtD
Orphenadrine—Aplastic anaemia—Methotrexate—urinary bladder cancer	0.00121	0.0113	CcSEcCtD
Orphenadrine—Agitation—Thiotepa—urinary bladder cancer	0.00121	0.0112	CcSEcCtD
Orphenadrine—SLC6A2—lymph node—urinary bladder cancer	0.00119	0.0116	CbGeAlD
Orphenadrine—Aplastic anaemia—Epirubicin—urinary bladder cancer	0.00114	0.0105	CcSEcCtD
Orphenadrine—CYP3A4—female reproductive system—urinary bladder cancer	0.00113	0.011	CbGeAlD
Orphenadrine—Confusional state—Thiotepa—urinary bladder cancer	0.00108	0.01	CcSEcCtD
Orphenadrine—KCNH2—lymph node—urinary bladder cancer	0.00106	0.0104	CbGeAlD
Orphenadrine—Aplastic anaemia—Doxorubicin—urinary bladder cancer	0.00105	0.00976	CcSEcCtD
Orphenadrine—Tachycardia—Thiotepa—urinary bladder cancer	0.00105	0.00971	CcSEcCtD
Orphenadrine—Skin disorder—Thiotepa—urinary bladder cancer	0.00104	0.00966	CcSEcCtD
Orphenadrine—Tamoxifen—ESR2—urinary bladder cancer	0.00103	0.147	CrCbGaD
Orphenadrine—Vision blurred—Fluorouracil—urinary bladder cancer	0.00102	0.0095	CcSEcCtD
Orphenadrine—Vision blurred—Cisplatin—urinary bladder cancer	0.000971	0.00901	CcSEcCtD
Orphenadrine—Tremor—Cisplatin—urinary bladder cancer	0.000965	0.00896	CcSEcCtD
Orphenadrine—Somnolence—Thiotepa—urinary bladder cancer	0.000953	0.00885	CcSEcCtD
Orphenadrine—Constipation—Thiotepa—urinary bladder cancer	0.000917	0.00851	CcSEcCtD
Orphenadrine—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.000902	0.00837	CcSEcCtD
Orphenadrine—Confusional state—Fluorouracil—urinary bladder cancer	0.000894	0.0083	CcSEcCtD
Orphenadrine—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.000887	0.00823	CcSEcCtD
Orphenadrine—Feeling abnormal—Thiotepa—urinary bladder cancer	0.000884	0.0082	CcSEcCtD
Orphenadrine—Skin disorder—Gemcitabine—urinary bladder cancer	0.000876	0.00813	CcSEcCtD
Orphenadrine—Tachycardia—Fluorouracil—urinary bladder cancer	0.000866	0.00803	CcSEcCtD
Orphenadrine—HRH1—lymph node—urinary bladder cancer	0.000853	0.00831	CbGeAlD
Orphenadrine—Urticaria—Thiotepa—urinary bladder cancer	0.000852	0.0079	CcSEcCtD
Orphenadrine—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000841	0.0078	CcSEcCtD
Orphenadrine—Tachycardia—Cisplatin—urinary bladder cancer	0.000821	0.00761	CcSEcCtD
Orphenadrine—Skin disorder—Cisplatin—urinary bladder cancer	0.000817	0.00758	CcSEcCtD
Orphenadrine—Somnolence—Gemcitabine—urinary bladder cancer	0.000802	0.00744	CcSEcCtD
Orphenadrine—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00079	0.00733	CcSEcCtD
Orphenadrine—Somnolence—Fluorouracil—urinary bladder cancer	0.000789	0.00732	CcSEcCtD
Orphenadrine—Confusional state—Etoposide—urinary bladder cancer	0.000777	0.00721	CcSEcCtD
Orphenadrine—Constipation—Gemcitabine—urinary bladder cancer	0.000771	0.00716	CcSEcCtD
Orphenadrine—Anaphylactic shock—Etoposide—urinary bladder cancer	0.00077	0.00715	CcSEcCtD
Orphenadrine—Asthenia—Thiotepa—urinary bladder cancer	0.000769	0.00714	CcSEcCtD
Orphenadrine—Pruritus—Thiotepa—urinary bladder cancer	0.000759	0.00704	CcSEcCtD
Orphenadrine—Tachycardia—Etoposide—urinary bladder cancer	0.000752	0.00698	CcSEcCtD
Orphenadrine—Skin disorder—Etoposide—urinary bladder cancer	0.000748	0.00694	CcSEcCtD
Orphenadrine—Fenoprofen—PTGS2—urinary bladder cancer	0.000747	0.106	CrCbGaD
Orphenadrine—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000743	0.0069	CcSEcCtD
Orphenadrine—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000731	0.00678	CcSEcCtD
Orphenadrine—Drowsiness—Methotrexate—urinary bladder cancer	0.000723	0.00671	CcSEcCtD
Orphenadrine—Dizziness—Thiotepa—urinary bladder cancer	0.000709	0.00658	CcSEcCtD
Orphenadrine—Urticaria—Fluorouracil—urinary bladder cancer	0.000705	0.00654	CcSEcCtD
Orphenadrine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000693	0.00643	CcSEcCtD
Orphenadrine—Somnolence—Etoposide—urinary bladder cancer	0.000685	0.00635	CcSEcCtD
Orphenadrine—Vomiting—Thiotepa—urinary bladder cancer	0.000682	0.00633	CcSEcCtD
Orphenadrine—Drowsiness—Epirubicin—urinary bladder cancer	0.000677	0.00628	CcSEcCtD
Orphenadrine—Headache—Thiotepa—urinary bladder cancer	0.000672	0.00623	CcSEcCtD
Orphenadrine—Constipation—Etoposide—urinary bladder cancer	0.000659	0.00611	CcSEcCtD
Orphenadrine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000653	0.00606	CcSEcCtD
Orphenadrine—Asthenia—Gemcitabine—urinary bladder cancer	0.000647	0.00601	CcSEcCtD
Orphenadrine—Pruritus—Gemcitabine—urinary bladder cancer	0.000638	0.00592	CcSEcCtD
Orphenadrine—Nausea—Thiotepa—urinary bladder cancer	0.000637	0.00591	CcSEcCtD
Orphenadrine—Feeling abnormal—Etoposide—urinary bladder cancer	0.000635	0.00589	CcSEcCtD
Orphenadrine—Tamoxifen—ESR1—urinary bladder cancer	0.000634	0.0903	CrCbGaD
Orphenadrine—Pruritus—Fluorouracil—urinary bladder cancer	0.000628	0.00582	CcSEcCtD
Orphenadrine—Drowsiness—Doxorubicin—urinary bladder cancer	0.000626	0.00581	CcSEcCtD
Orphenadrine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000619	0.00575	CcSEcCtD
Orphenadrine—Urticaria—Etoposide—urinary bladder cancer	0.000612	0.00568	CcSEcCtD
Orphenadrine—Asthenia—Cisplatin—urinary bladder cancer	0.000603	0.0056	CcSEcCtD
Orphenadrine—Dizziness—Fluorouracil—urinary bladder cancer	0.000587	0.00544	CcSEcCtD
Orphenadrine—Vomiting—Gemcitabine—urinary bladder cancer	0.000574	0.00532	CcSEcCtD
Orphenadrine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000568	0.00527	CcSEcCtD
Orphenadrine—Headache—Gemcitabine—urinary bladder cancer	0.000565	0.00524	CcSEcCtD
Orphenadrine—Vomiting—Fluorouracil—urinary bladder cancer	0.000564	0.00523	CcSEcCtD
Orphenadrine—Headache—Fluorouracil—urinary bladder cancer	0.000556	0.00516	CcSEcCtD
Orphenadrine—Asthenia—Etoposide—urinary bladder cancer	0.000553	0.00513	CcSEcCtD
Orphenadrine—Pruritus—Etoposide—urinary bladder cancer	0.000545	0.00506	CcSEcCtD
Orphenadrine—Nausea—Gemcitabine—urinary bladder cancer	0.000536	0.00497	CcSEcCtD
Orphenadrine—Vomiting—Cisplatin—urinary bladder cancer	0.000535	0.00496	CcSEcCtD
Orphenadrine—Vision blurred—Methotrexate—urinary bladder cancer	0.000533	0.00494	CcSEcCtD
Orphenadrine—Nausea—Fluorouracil—urinary bladder cancer	0.000527	0.00489	CcSEcCtD
Orphenadrine—Tension—Epirubicin—urinary bladder cancer	0.000519	0.00482	CcSEcCtD
Orphenadrine—Dizziness—Etoposide—urinary bladder cancer	0.000509	0.00473	CcSEcCtD
Orphenadrine—Nausea—Cisplatin—urinary bladder cancer	0.000499	0.00463	CcSEcCtD
Orphenadrine—Vision blurred—Epirubicin—urinary bladder cancer	0.000499	0.00463	CcSEcCtD
Orphenadrine—Vomiting—Etoposide—urinary bladder cancer	0.00049	0.00454	CcSEcCtD
Orphenadrine—Agitation—Epirubicin—urinary bladder cancer	0.000486	0.00451	CcSEcCtD
Orphenadrine—Headache—Etoposide—urinary bladder cancer	0.000483	0.00448	CcSEcCtD
Orphenadrine—Tension—Doxorubicin—urinary bladder cancer	0.00048	0.00446	CcSEcCtD
Orphenadrine—Palpitations—Epirubicin—urinary bladder cancer	0.000468	0.00434	CcSEcCtD
Orphenadrine—Confusional state—Methotrexate—urinary bladder cancer	0.000465	0.00432	CcSEcCtD
Orphenadrine—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000461	0.00428	CcSEcCtD
Orphenadrine—Vision blurred—Doxorubicin—urinary bladder cancer	0.000461	0.00428	CcSEcCtD
Orphenadrine—Nausea—Etoposide—urinary bladder cancer	0.000458	0.00425	CcSEcCtD
Orphenadrine—Agitation—Doxorubicin—urinary bladder cancer	0.00045	0.00417	CcSEcCtD
Orphenadrine—Skin disorder—Methotrexate—urinary bladder cancer	0.000448	0.00416	CcSEcCtD
Orphenadrine—Confusional state—Epirubicin—urinary bladder cancer	0.000435	0.00404	CcSEcCtD
Orphenadrine—Palpitations—Doxorubicin—urinary bladder cancer	0.000433	0.00401	CcSEcCtD
Orphenadrine—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000432	0.00401	CcSEcCtD
Orphenadrine—Tachycardia—Epirubicin—urinary bladder cancer	0.000421	0.00391	CcSEcCtD
Orphenadrine—Skin disorder—Epirubicin—urinary bladder cancer	0.000419	0.00389	CcSEcCtD
Orphenadrine—Somnolence—Methotrexate—urinary bladder cancer	0.00041	0.00381	CcSEcCtD
Orphenadrine—Confusional state—Doxorubicin—urinary bladder cancer	0.000403	0.00374	CcSEcCtD
Orphenadrine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.0004	0.00371	CcSEcCtD
Orphenadrine—Tachycardia—Doxorubicin—urinary bladder cancer	0.00039	0.00362	CcSEcCtD
Orphenadrine—Skin disorder—Doxorubicin—urinary bladder cancer	0.000388	0.0036	CcSEcCtD
Orphenadrine—Somnolence—Epirubicin—urinary bladder cancer	0.000384	0.00356	CcSEcCtD
Orphenadrine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.00038	0.00353	CcSEcCtD
Orphenadrine—Constipation—Epirubicin—urinary bladder cancer	0.000369	0.00343	CcSEcCtD
Orphenadrine—Urticaria—Methotrexate—urinary bladder cancer	0.000367	0.0034	CcSEcCtD
Orphenadrine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000356	0.0033	CcSEcCtD
Orphenadrine—Somnolence—Doxorubicin—urinary bladder cancer	0.000355	0.0033	CcSEcCtD
Orphenadrine—Urticaria—Epirubicin—urinary bladder cancer	0.000343	0.00318	CcSEcCtD
Orphenadrine—Constipation—Doxorubicin—urinary bladder cancer	0.000342	0.00317	CcSEcCtD
Orphenadrine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.00034	0.00315	CcSEcCtD
Orphenadrine—Asthenia—Methotrexate—urinary bladder cancer	0.000331	0.00307	CcSEcCtD
Orphenadrine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000329	0.00305	CcSEcCtD
Orphenadrine—Pruritus—Methotrexate—urinary bladder cancer	0.000326	0.00303	CcSEcCtD
Orphenadrine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000318	0.00295	CcSEcCtD
Orphenadrine—Urticaria—Doxorubicin—urinary bladder cancer	0.000317	0.00294	CcSEcCtD
Orphenadrine—Asthenia—Epirubicin—urinary bladder cancer	0.00031	0.00287	CcSEcCtD
Orphenadrine—Pruritus—Epirubicin—urinary bladder cancer	0.000305	0.00283	CcSEcCtD
Orphenadrine—Dizziness—Methotrexate—urinary bladder cancer	0.000305	0.00283	CcSEcCtD
Orphenadrine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000294	0.00273	CcSEcCtD
Orphenadrine—Vomiting—Methotrexate—urinary bladder cancer	0.000293	0.00272	CcSEcCtD
Orphenadrine—Headache—Methotrexate—urinary bladder cancer	0.000289	0.00268	CcSEcCtD
Orphenadrine—Asthenia—Doxorubicin—urinary bladder cancer	0.000287	0.00266	CcSEcCtD
Orphenadrine—Dizziness—Epirubicin—urinary bladder cancer	0.000286	0.00265	CcSEcCtD
Orphenadrine—Pruritus—Doxorubicin—urinary bladder cancer	0.000283	0.00262	CcSEcCtD
Orphenadrine—Vomiting—Epirubicin—urinary bladder cancer	0.000275	0.00255	CcSEcCtD
Orphenadrine—Nausea—Methotrexate—urinary bladder cancer	0.000274	0.00254	CcSEcCtD
Orphenadrine—Headache—Epirubicin—urinary bladder cancer	0.000271	0.00251	CcSEcCtD
Orphenadrine—Dizziness—Doxorubicin—urinary bladder cancer	0.000264	0.00245	CcSEcCtD
Orphenadrine—Nausea—Epirubicin—urinary bladder cancer	0.000256	0.00238	CcSEcCtD
Orphenadrine—Vomiting—Doxorubicin—urinary bladder cancer	0.000254	0.00236	CcSEcCtD
Orphenadrine—Headache—Doxorubicin—urinary bladder cancer	0.00025	0.00232	CcSEcCtD
Orphenadrine—Nausea—Doxorubicin—urinary bladder cancer	0.000237	0.0022	CcSEcCtD
Orphenadrine—SCN9A—Axon guidance—KRAS—urinary bladder cancer	0.000135	0.00101	CbGpPWpGaD
Orphenadrine—CHRM2—Regulation of Actin Cytoskeleton—RHOA—urinary bladder cancer	0.000133	0.000992	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—PPARG—urinary bladder cancer	0.000133	0.000987	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—EGFR—urinary bladder cancer	0.000131	0.000978	CbGpPWpGaD
Orphenadrine—GRIN2D—Neuronal System—HRAS—urinary bladder cancer	0.000131	0.000975	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—ERBB2—urinary bladder cancer	0.00013	0.000971	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—ERBB2—urinary bladder cancer	0.00013	0.000971	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—ERBB2—urinary bladder cancer	0.000128	0.000957	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—MMP9—urinary bladder cancer	0.000128	0.000955	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—CREBBP—urinary bladder cancer	0.000127	0.000948	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—EGFR—urinary bladder cancer	0.000127	0.000943	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—EGFR—urinary bladder cancer	0.000127	0.000943	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—MMP9—urinary bladder cancer	0.000126	0.00094	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—CDK4—urinary bladder cancer	0.000125	0.000934	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—KRAS—urinary bladder cancer	0.000124	0.000924	CbGpPWpGaD
Orphenadrine—GRIN1—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	0.000122	0.000911	CbGpPWpGaD
Orphenadrine—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	0.000122	0.000907	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—EP300—urinary bladder cancer	0.00012	0.000891	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—KRAS—urinary bladder cancer	0.00012	0.000891	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—KRAS—urinary bladder cancer	0.00012	0.000891	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—SRC—urinary bladder cancer	0.000118	0.00088	CbGpPWpGaD
Orphenadrine—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	0.000118	0.00088	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—SRC—urinary bladder cancer	0.000116	0.000867	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—MMP9—urinary bladder cancer	0.000116	0.000864	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—RHOA—urinary bladder cancer	0.000115	0.000858	CbGpPWpGaD
Orphenadrine—SCN9A—Axon guidance—HRAS—urinary bladder cancer	0.000115	0.000855	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—PPARG—urinary bladder cancer	0.000114	0.000848	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	0.000113	0.00084	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—MMP9—urinary bladder cancer	0.000112	0.000833	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—MMP9—urinary bladder cancer	0.000112	0.000833	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GSTZ1—urinary bladder cancer	0.00011	0.000822	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—MMP9—urinary bladder cancer	0.00011	0.00082	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—EP300—urinary bladder cancer	0.00011	0.000819	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—CREBBP—urinary bladder cancer	0.000109	0.000815	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GSTZ1—urinary bladder cancer	0.000108	0.000806	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—SRC—urinary bladder cancer	0.000107	0.000796	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—ERBB2—urinary bladder cancer	0.000107	0.000794	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—EP300—urinary bladder cancer	0.000106	0.00079	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—EP300—urinary bladder cancer	0.000106	0.00079	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—HRAS—urinary bladder cancer	0.000105	0.000785	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GSTO2—urinary bladder cancer	0.000105	0.00078	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—NAT1—urinary bladder cancer	0.000105	0.00078	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—EGFR—urinary bladder cancer	0.000104	0.000772	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—SRC—urinary bladder cancer	0.000103	0.000768	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—SRC—urinary bladder cancer	0.000103	0.000768	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GSTO2—urinary bladder cancer	0.000103	0.000764	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—NAT1—urinary bladder cancer	0.000103	0.000764	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—EGFR—urinary bladder cancer	0.000102	0.000759	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—HRAS—urinary bladder cancer	0.000102	0.000757	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—HRAS—urinary bladder cancer	0.000102	0.000757	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—SRC—urinary bladder cancer	0.000102	0.000756	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—RHOA—urinary bladder cancer	9.9e-05	0.000737	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—KRAS—urinary bladder cancer	9.79e-05	0.000729	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—TNF—urinary bladder cancer	9.71e-05	0.000723	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	9.67e-05	0.00072	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—KRAS—urinary bladder cancer	9.63e-05	0.000717	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—UGT2B7—urinary bladder cancer	9.57e-05	0.000713	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—UGT2B7—urinary bladder cancer	9.38e-05	0.000698	CbGpPWpGaD
Orphenadrine—GRIN1—Neuronal System—HRAS—urinary bladder cancer	9.37e-05	0.000698	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—EGFR—urinary bladder cancer	9.37e-05	0.000698	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—ERBB2—urinary bladder cancer	9.16e-05	0.000683	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—MMP9—urinary bladder cancer	9.15e-05	0.000681	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—EGFR—urinary bladder cancer	9.04e-05	0.000673	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—EGFR—urinary bladder cancer	9.04e-05	0.000673	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—TNF—urinary bladder cancer	8.92e-05	0.000665	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—EGFR—urinary bladder cancer	8.9e-05	0.000663	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—KRAS—urinary bladder cancer	8.85e-05	0.000659	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—EP300—urinary bladder cancer	8.67e-05	0.000646	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CYP4B1—urinary bladder cancer	8.62e-05	0.000642	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—TNF—urinary bladder cancer	8.61e-05	0.000641	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—TNF—urinary bladder cancer	8.61e-05	0.000641	CbGpPWpGaD
Orphenadrine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—urinary bladder cancer	8.55e-05	0.000637	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—KRAS—urinary bladder cancer	8.54e-05	0.000636	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—KRAS—urinary bladder cancer	8.54e-05	0.000636	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CYP4B1—urinary bladder cancer	8.44e-05	0.000629	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—SRC—urinary bladder cancer	8.43e-05	0.000628	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—KRAS—urinary bladder cancer	8.41e-05	0.000626	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—HRAS—urinary bladder cancer	8.32e-05	0.000619	CbGpPWpGaD
Orphenadrine—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	8.19e-05	0.00061	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—HRAS—urinary bladder cancer	8.19e-05	0.00061	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—SLC19A1—urinary bladder cancer	8.14e-05	0.000606	CbGpPWpGaD
Orphenadrine—CHRM2—G alpha (i) signalling events—CXCL8—urinary bladder cancer	8.12e-05	0.000605	CbGpPWpGaD
Orphenadrine—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	8.08e-05	0.000602	CbGpPWpGaD
Orphenadrine—CHRM2—Regulation of Actin Cytoskeleton—KRAS—urinary bladder cancer	8.07e-05	0.000601	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—SLC19A1—urinary bladder cancer	7.97e-05	0.000594	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PRSS3—urinary bladder cancer	7.93e-05	0.000591	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—MMP9—urinary bladder cancer	7.86e-05	0.000585	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	7.85e-05	0.000584	CbGpPWpGaD
Orphenadrine—KCNH2—Neuronal System—HRAS—urinary bladder cancer	7.81e-05	0.000582	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PRSS3—urinary bladder cancer	7.77e-05	0.000579	CbGpPWpGaD
Orphenadrine—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	7.53e-05	0.000561	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—HRAS—urinary bladder cancer	7.52e-05	0.00056	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—EP300—urinary bladder cancer	7.45e-05	0.000555	CbGpPWpGaD
Orphenadrine—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	7.42e-05	0.000553	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HDAC4—urinary bladder cancer	7.4e-05	0.000551	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—EGFR—urinary bladder cancer	7.39e-05	0.000551	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HDAC4—urinary bladder cancer	7.28e-05	0.000543	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—HRAS—urinary bladder cancer	7.26e-05	0.00054	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—HRAS—urinary bladder cancer	7.26e-05	0.00054	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—SRC—urinary bladder cancer	7.25e-05	0.00054	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—HRAS—urinary bladder cancer	7.15e-05	0.000532	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—TNF—urinary bladder cancer	7.04e-05	0.000524	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—KRAS—urinary bladder cancer	6.98e-05	0.00052	CbGpPWpGaD
Orphenadrine—SLC6A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.97e-05	0.000519	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	6.56e-05	0.000489	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—urinary bladder cancer	6.48e-05	0.000482	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	6.46e-05	0.000481	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—EGFR—urinary bladder cancer	6.35e-05	0.000473	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—TYMP—urinary bladder cancer	6.34e-05	0.000472	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—TYMP—urinary bladder cancer	6.21e-05	0.000463	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—GLI1—urinary bladder cancer	6.2e-05	0.000462	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—urinary bladder cancer	6.12e-05	0.000456	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—GLI1—urinary bladder cancer	6.1e-05	0.000455	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—TNF—urinary bladder cancer	6.05e-05	0.000451	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—KRAS—urinary bladder cancer	6e-05	0.000447	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—HRAS—urinary bladder cancer	5.94e-05	0.000442	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—NAT2—urinary bladder cancer	5.74e-05	0.000427	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—NAT2—urinary bladder cancer	5.62e-05	0.000418	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—urinary bladder cancer	5.2e-05	0.000387	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—HRAS—urinary bladder cancer	5.1e-05	0.00038	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	5.02e-05	0.000374	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—CXCL8—urinary bladder cancer	5e-05	0.000372	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—RRM2—urinary bladder cancer	4.95e-05	0.000369	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—CXCL8—urinary bladder cancer	4.92e-05	0.000366	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—RRM2—urinary bladder cancer	4.85e-05	0.000361	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	4.76e-05	0.000354	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—NAT1—urinary bladder cancer	4.76e-05	0.000354	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ENO2—urinary bladder cancer	4.59e-05	0.000342	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—HPGDS—urinary bladder cancer	4.59e-05	0.000342	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—HPGDS—urinary bladder cancer	4.49e-05	0.000334	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ENO2—urinary bladder cancer	4.49e-05	0.000334	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GSTT1—urinary bladder cancer	4.45e-05	0.000331	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GSTT1—urinary bladder cancer	4.36e-05	0.000324	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	4.35e-05	0.000324	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—RBX1—urinary bladder cancer	4.25e-05	0.000317	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—RBX1—urinary bladder cancer	4.18e-05	0.000312	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TSC1—urinary bladder cancer	4e-05	0.000298	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TSC1—urinary bladder cancer	3.93e-05	0.000293	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	3.92e-05	0.000292	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—JAG1—urinary bladder cancer	3.81e-05	0.000283	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—JAG1—urinary bladder cancer	3.74e-05	0.000279	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	3.7e-05	0.000276	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—NQO1—urinary bladder cancer	3.7e-05	0.000275	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—NQO1—urinary bladder cancer	3.62e-05	0.00027	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	3.61e-05	0.000269	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—RHOA—urinary bladder cancer	3.22e-05	0.00024	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—RHOA—urinary bladder cancer	3.17e-05	0.000236	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	3.08e-05	0.00023	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—S100B—urinary bladder cancer	3.08e-05	0.00023	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—S100B—urinary bladder cancer	3.03e-05	0.000226	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	3.02e-05	0.000225	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—RHOA—urinary bladder cancer	2.92e-05	0.000218	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	2.88e-05	0.000215	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—RHOA—urinary bladder cancer	2.87e-05	0.000214	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—TYMS—urinary bladder cancer	2.87e-05	0.000213	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	2.83e-05	0.000211	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	2.83e-05	0.000211	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—CXCL8—urinary bladder cancer	2.82e-05	0.00021	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—TYMS—urinary bladder cancer	2.81e-05	0.000209	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—CXCL8—urinary bladder cancer	2.78e-05	0.000207	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	2.77e-05	0.000207	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	2.77e-05	0.000207	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NCOR1—urinary bladder cancer	2.77e-05	0.000206	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NCOR1—urinary bladder cancer	2.73e-05	0.000203	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GPX1—urinary bladder cancer	2.71e-05	0.000202	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—IL2—urinary bladder cancer	2.7e-05	0.000201	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	2.66e-05	0.000198	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GPX1—urinary bladder cancer	2.66e-05	0.000198	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—IL2—urinary bladder cancer	2.66e-05	0.000198	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	2.61e-05	0.000194	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	2.61e-05	0.000194	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CXCL8—urinary bladder cancer	2.56e-05	0.000191	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CXCL8—urinary bladder cancer	2.52e-05	0.000188	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	2.5e-05	0.000186	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	2.45e-05	0.000183	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—IL2—urinary bladder cancer	2.45e-05	0.000183	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TERT—urinary bladder cancer	2.44e-05	0.000182	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—IL2—urinary bladder cancer	2.41e-05	0.00018	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TERT—urinary bladder cancer	2.4e-05	0.000179	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	2.25e-05	0.000168	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—FGFR3—urinary bladder cancer	2.24e-05	0.000167	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—FGFR3—urinary bladder cancer	2.21e-05	0.000164	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ESR1—urinary bladder cancer	2.18e-05	0.000162	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ESR1—urinary bladder cancer	2.14e-05	0.00016	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	2.08e-05	0.000155	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	2.08e-05	0.000155	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PPARG—urinary bladder cancer	2.03e-05	0.000151	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	2.02e-05	0.000151	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PPARG—urinary bladder cancer	1.99e-05	0.000148	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	1.95e-05	0.000145	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	1.91e-05	0.000142	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CREBBP—urinary bladder cancer	1.91e-05	0.000142	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IGF1—urinary bladder cancer	1.88e-05	0.00014	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CREBBP—urinary bladder cancer	1.88e-05	0.00014	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—EGFR—urinary bladder cancer	1.87e-05	0.00014	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IGF1—urinary bladder cancer	1.85e-05	0.000138	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—EGFR—urinary bladder cancer	1.84e-05	0.000137	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—KRAS—urinary bladder cancer	1.77e-05	0.000132	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—KRAS—urinary bladder cancer	1.74e-05	0.00013	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—RHOA—urinary bladder cancer	1.73e-05	0.000129	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—RHOA—urinary bladder cancer	1.7e-05	0.000126	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.68e-05	0.000125	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ERBB2—urinary bladder cancer	1.6e-05	0.000119	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	1.6e-05	0.000119	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ERBB2—urinary bladder cancer	1.57e-05	0.000117	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	1.56e-05	0.000117	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CXCL8—urinary bladder cancer	1.52e-05	0.000113	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—HRAS—urinary bladder cancer	1.51e-05	0.000112	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CXCL8—urinary bladder cancer	1.49e-05	0.000111	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—HRAS—urinary bladder cancer	1.48e-05	0.00011	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IL2—urinary bladder cancer	1.45e-05	0.000108	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IL2—urinary bladder cancer	1.42e-05	0.000106	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CCND1—urinary bladder cancer	1.41e-05	0.000105	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.4e-05	0.000104	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PTEN—urinary bladder cancer	1.39e-05	0.000104	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CCND1—urinary bladder cancer	1.39e-05	0.000103	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MMP9—urinary bladder cancer	1.37e-05	0.000102	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CDKN1A—urinary bladder cancer	1.37e-05	0.000102	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PTEN—urinary bladder cancer	1.36e-05	0.000102	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PTEN—urinary bladder cancer	1.36e-05	0.000101	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MMP9—urinary bladder cancer	1.35e-05	0.0001	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CDKN1A—urinary bladder cancer	1.34e-05	0.0001	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PTEN—urinary bladder cancer	1.34e-05	9.98e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—EP300—urinary bladder cancer	1.33e-05	9.89e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.3e-05	9.7e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—EP300—urinary bladder cancer	1.3e-05	9.69e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—EP300—urinary bladder cancer	1.3e-05	9.68e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.29e-05	9.59e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.29e-05	9.59e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—EP300—urinary bladder cancer	1.28e-05	9.52e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—SRC—urinary bladder cancer	1.26e-05	9.41e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—SRC—urinary bladder cancer	1.24e-05	9.26e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.23e-05	9.18e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.21e-05	9.01e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.14e-05	8.47e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MYC—urinary bladder cancer	1.13e-05	8.43e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MYC—urinary bladder cancer	1.11e-05	8.3e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—EGFR—urinary bladder cancer	1.11e-05	8.25e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—EGFR—urinary bladder cancer	1.09e-05	8.12e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—KRAS—urinary bladder cancer	1.05e-05	7.79e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—KRAS—urinary bladder cancer	1.03e-05	7.67e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TP53—urinary bladder cancer	9.3e-06	6.93e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	9.23e-06	6.87e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TP53—urinary bladder cancer	9.15e-06	6.81e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HRAS—urinary bladder cancer	8.89e-06	6.62e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	8.86e-06	6.6e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HRAS—urinary bladder cancer	8.75e-06	6.52e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	7.26e-06	5.41e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	6.33e-06	4.71e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—EP300—urinary bladder cancer	6.04e-06	4.5e-05	CbGpPWpGaD
